To confirm that CNP/NPR-C signaling is critical as a host defense mechanism to prevent TAA and AAA and to offer promise that targeting this pathway might be of therapeutic benefit, we examined the effect of CNP administration on progression of AA in Ang II–infused WT and NPR-C−/− mice. The gene discussed is CNP; the disease is triple-A syndrome.